Related Experiment Video

Updated: Jul 16, 2026

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
06:00

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics

Published on: May 14, 2016

Arrest of cancer cell proliferation by dsRNAs

Tatyana O Kabilova1, Al 'Bina V Vladimirova, Elena L Chernolovskaya

  • 1Institute of Chemical Biology and Fundamental Medicine, Siberian Branch-Russian Academy of Sciences, Lavrentiev Avenue 8, Novosibirsk 630090, Russia.

Annals of the New York Academy of Sciences
|March 8, 2007
PubMed

Insights

Short interfering RNAs (siRNAs) targeting c-myc and N-myc genes inhibited proliferation in cancer cells. Specific siRNAs demonstrated antiproliferative effects by downregulating oncogene expression, offering potential therapeutic strategies.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • RNA Interference

Background:

  • c-myc and N-myc genes are crucial oncogenes implicated in various cancers, including neuroblastoma and carcinoma.
  • Targeting these genes with RNA interference (RNAi) presents a potential therapeutic strategy for cancer treatment.

Purpose of the Study:

  • To investigate the efficacy of double-stranded RNAs (dsRNAs), including small interfering RNAs (siRNAs), in inhibiting the expression of c-myc and N-myc genes.
  • To evaluate the antiproliferative effects of these dsRNAs on carcinoma and neuroblastoma cell lines.

Main Methods:

  • Design and application of specific siRNAs targeting different exons of c-myc and N-myc genes.
  • Assessment of gene expression levels (mRNA) and cellular proliferation rates in response to dsRNA treatment.
  • Utilizing long dsRNA (dsMyc) and interferon inducers (poly(I:C)) to study antiproliferative mechanisms.

Main Results:

  • siRNA-Ex3 specifically downregulated c-myc mRNA and inhibited proliferation in c-myc-overexpressing cells, but not N-myc-overexpressing cells.
  • siRNA-Ex2, targeting a conserved region of both c-myc and N-myc, downregulated both genes and reduced proliferation in multiple cell lines.
  • dsMyc, poly(I:C), and a GU-rich siRNA also exhibited significant antiproliferative activity, with poly(I:C) transiently increasing PKR and OAS1 mRNA levels.

Conclusions:

  • Specific dsRNAs can effectively inhibit c-myc and N-myc gene expression and suppress cancer cell proliferation.
  • The antiproliferative effects are mediated through RNA interference and potentially interferon-mediated pathways.
  • These findings support the development of dsRNA-based therapeutics for cancers driven by c-myc and N-myc.

More Related Videos

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells07:23

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells

Published on: May 30, 2025

Silencing of BRCA2 to Identify Novel BRCA2-regulated Biological Functions in Cultured Human Cells09:24

Silencing of BRCA2 to Identify Novel BRCA2-regulated Biological Functions in Cultured Human Cells

Published on: August 12, 2015

Related Concept Videos

Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...